Terms: = Ovarian cancer AND ER, estrogen receptor AND Treatment
724 results:
1. ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC.
Böpple K; Oren Y; Henry WS; Dong M; Weller S; Thiel J; Kleih M; Gaißler A; Zipperer D; Kopp HG; Aylon Y; Oren M; Essmann F; Liang C; Aulitzky WE
Cell Death Dis; 2024 Apr; 15(4):290. PubMed ID: 38658567
[TBL] [Abstract] [Full Text] [Related]
2. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast cancer: A Randomized Clinical Study.
Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
[TBL] [Abstract] [Full Text] [Related]
3. High incidence of imperforate vagina in ADGRA3-deficient mice.
Kvam JM; Nybo ML; Torz L; Sustarsic RK; Jensen KHR; Nielsen JE; Frederiksen H; Gadgaard S; Spiess K; Poulsen SS; Thomsen JS; Cowin P; Blomberg Jensen M; Kurita T; Rosenkilde MM
BMC Biol; 2024 Apr; 22(1):77. PubMed ID: 38589878
[TBL] [Abstract] [Full Text] [Related]
4. Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response.
Hu Z; Wu Z; Liu W; Ning Y; Liu J; Ding W; Fan J; Cai S; Li Q; Li W; Yang X; Dou Y; Wang W; Peng W; Lu F; Zhuang X; Qin T; Kang X; Feng C; Xu Z; Lv Q; Wang Q; Wang C; Wang X; Wang Z; Wang J; Jiang J; Wang B; Mills GB; Ma D; Gao Q; Li K; Chen G; Chen X; Sun C
Nat Genet; 2024 Apr; 56(4):637-651. PubMed ID: 38565644
[TBL] [Abstract] [Full Text] [Related]
5. Mesonephric-like adenocarcinoma of the ovary.
Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
[TBL] [Abstract] [Full Text] [Related]
6. Unfolded Protein-Based Sandwich AIE Probe Imparts High Fluorescent Contrast for Pan-cancer Surgical Navigation.
Wang Q; Chen B; Duan C; Wang T; Lou X; Dai J; Xia F
Anal Chem; 2024 Feb; 96(8):3609-3617. PubMed ID: 38364862
[TBL] [Abstract] [Full Text] [Related]
7. AURKA Enhances the Glycolysis and Development of ovarian Endometriosis Through ERβ.
Sun Y; Zhang S; Zhang X; Li G; Sun F; Wang M; Ren C; Jiang A; Yang T
Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38340326
[TBL] [Abstract] [Full Text] [Related]
8. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
[TBL] [Abstract] [Full Text] [Related]
9. Benzo[a]pyrene exposure affects colorectal cancer susceptibility by regulating ERβ-mediated LINC02977 transcription.
Ben S; Li S; Gu D; Zhao L; Xu S; Ding Z; Chen S; Cheng Y; Xin J; Du M; Wang M
Environ Int; 2024 Feb; 184():108443. PubMed ID: 38277997
[TBL] [Abstract] [Full Text] [Related]
10. PAX2 is regulated by estrogen/progesterone through promoter methylation in endometrioid adenocarcinoma and has an important role in carcinogenesis via the AKT/mTOR signaling pathway.
Chen H; Li L; Liu H; Qin P; Chen R; Liu S; Xiong H; Li Y; Yang Z; Xie M; Yang H; Jiang Q
J Pathol; 2024 Apr; 262(4):467-479. PubMed ID: 38185904
[TBL] [Abstract] [Full Text] [Related]
11. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
12. Long-Term Follow-Up of Tamoxifen treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges.
Gideonsson I; Israelsson P; Strandberg SN; Ottander U
Curr Oncol; 2023 Nov; 30(12):10260-10271. PubMed ID: 38132381
[TBL] [Abstract] [Full Text] [Related]
13. Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
Bae SJ; Kim HJ; Kim HA; Ryu JM; Park S; Lee EG; Im SA; Jung Y; Park MH; Park KH; Kang SH; Park E; Kim SY; Lee MH; Kim LS; Lee A; Noh WC; Gwark S; Kim S; Jeong J
Int J Surg; 2024 Feb; 110(2):934-942. PubMed ID: 38000057
[TBL] [Abstract] [Full Text] [Related]
14. External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Wang Y; Broeks A; Giardiello D; Hauptmann M; Jóźwiak K; Koop EA; Opdam M; Siesling S; Sonke GS; Stathonikos N; Ter Hoeve ND; van der Wall E; van Deurzen CHM; van Diest PJ; Voogd AC; Vreuls W; Linn SC; Dackus GMHE; Schmidt MK
Eur J Cancer; 2023 Dec; 195():113401. PubMed ID: 37925965
[TBL] [Abstract] [Full Text] [Related]
15. Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast cancer: An Expert Consensus on Open Issues for Future Research.
Conforti F; Pala L; De Pas T; Zattarin E; Catania C; Cocorocchio E; Rossi G; Laszlo D; Colleoni M; Zambelli A; Hortobagyi GN; Cortes J; Piccart MJ; Dowsett M; Gelber RD; Viale G
Clin Cancer Res; 2024 Mar; 30(6):1093-1103. PubMed ID: 37906083
[TBL] [Abstract] [Full Text] [Related]
16. cancer stemness kinase inhibitor amcasertib: a promising therapeutic agent in ovarian cancer stem and cancer cell models with different genetic profiles.
Guler Kara H; Ozates NP; Asik A; Gunduz C
Med Oncol; 2023 Oct; 40(12):342. PubMed ID: 37891391
[TBL] [Abstract] [Full Text] [Related]
17. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
[No Abstract] [Full Text] [Related]
18. The TGFBI gene and protein expression in topotecan resistant ovarian cancer cell lines.
Wojtowicz K; Świerczewska M; Nowicki M; Januchowski R
Adv Med Sci; 2023 Sep; 68(2):379-385. PubMed ID: 37806183
[TBL] [Abstract] [Full Text] [Related]
19. MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER.
Boscaro C; Ramaschi GE; Trevisi L; Cignarella A; Bolego C
Life Sci; 2023 Nov; 333():122135. PubMed ID: 37778413
[TBL] [Abstract] [Full Text] [Related]
20. Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives.
Nahmias-Blank D; Maimon O; Meirovitz A; Sheva K; Peretz-Yablonski T; Elkin M
Semin Cancer Biol; 2023 Nov; 96():26-35. PubMed ID: 37739109
[TBL] [Abstract] [Full Text] [Related]
[Next]